Immune reconstitution after unrelated cord blood transplantation

References

• Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. A new method. Va Med Mon (1918) 1972; 99: 276–80
   PubMedGoogle Scholar
• Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–32
   PubMed Web of Science ®Google Scholar
• Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 2005; 7: 219–27
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE. Biology of cord blood cells and future prospects for enhanced clinical benefit. Cytotherapy 2005; 7: 209–18
   PubMed Web of Science ®Google Scholar
• Leung W, Ramirez M, Civin CI. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biol Blood Marrow Transplant 1999; 5: 69–76
   Google Scholar
• Frassoni F, Podesta M, Maccario R, et al. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 2003; 102: 1138–41
   Google Scholar
• Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–8
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119–22
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Graham M, Casey J, et al. The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20: 275–83
   PubMedGoogle Scholar
• Rocha V, Gluckman E. Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12: 34–41
   PubMedGoogle Scholar
• Barker JN, Davies SM, DeFor T, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–61
   PubMed Web of Science ®Google Scholar
• Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–71
   PubMed Web of Science ®Google Scholar
• Koh LP, Chao NJ. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens. Biol Blood Marrow Transplant 2004; 10: 1–22
   PubMed Web of Science ®Google Scholar
• Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–77
   PubMed Web of Science ®Google Scholar
• Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276–85
   PubMed Web of Science ®Google Scholar
• Kurtzberg J, Carter SL, Baxter-Lowe LA , et al. Results of the cord blood transplantation study (COBLT): clinical outcomes of 193 unrelated donor umbilical cord blood transplantation in pediatric patients with malignant conditions. Biol Blood Marrow Transplant 2005;11: Suppl 1:6.
   Google Scholar
• Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–75
   PubMed Web of Science ®Google Scholar
• Parody R, Martino R, Rovira M, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12: 734–48
   PubMed Web of Science ®Google Scholar
• Barker JN, Hough RE, Van Burik JA, et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11: 362–70
   PubMed Web of Science ®Google Scholar
• Cohen G, Carter SL, Weinberg KI, et al. Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 2006; 12: 1335–42
   PubMedGoogle Scholar
• Fry TJ, Mackall CL. Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future. Bone Marrow Transplant 2005; 35(Suppl 1)S53–7
   Google Scholar
• Parkman R, Weinberg KI. Immunological reconstitution following bone marrow transplantation. Immunol Rev 1997; 157: 73–8
   PubMed Web of Science ®Google Scholar
• Parkman R. Antigen-specific immune function after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2003; 9: 287–91
   Google Scholar
• Crooks GM, Weinberg K, Mackall C. Immune reconstitution: from stem cells to lymphocytes. Biol Blood Marrow Transplant 2006; 12: 42–6
   PubMed Web of Science ®Google Scholar
• Mackall CL, Bare CV, Granger LA, et al. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156: 4609–16
   PubMed Web of Science ®Google Scholar
• Garderet L, Dulphy N, Douay C, et al. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998; 91: 340–6
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, American Association of Blood Banks. Cord Blood: Biology, Immunology, and Clinical Transplantation. Bethesda: AABB Press, 2004.
   Google Scholar
• Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002; 99: 1458–64
   PubMed Web of Science ®Google Scholar
• Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995; 89: 733–40
   PubMed Web of Science ®Google Scholar
• D'Arena G, Musto P, Cascavilla N, et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 1998; 83: 197–203
   PubMed Web of Science ®Google Scholar
• Szabolcs P, Park KD, Reese M, et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp Hematol 2003; 31: 708–14
   PubMed Web of Science ®Google Scholar
• Chalmers IM, Janossy G, Contreras M, Navarrete C. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92: 11–8
   PubMed Web of Science ®Google Scholar
• Risdon G, Gaddy J, Stehman FB, Broxmeyer HE. Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation. Cell Immunol 1994; 154: 14–24
   PubMed Web of Science ®Google Scholar
• Suen Y, Lee SM, Qian J, et al. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity. Vaccine 1998; 16: 1369–77
   PubMed Web of Science ®Google Scholar
• Bradley MB, Cairo MS. Cord blood immunology and stem cell transplantation. Hum Immunol 2005; 66: 431–46
   Google Scholar
• Berthou C, Legros-Maida S, Soulie A, et al. Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 1995; 85: 1540–6
   Google Scholar
• Godfrey WR, Spoden DJ, Ge YG, et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750–8
   PubMed Web of Science ®Google Scholar
• Schonland SO, Zimmer JK, Lopez-Benitez CM, et al. Homeostatic control of T-cell generation in neonates. Blood 2003; 102: 1428–34
   PubMed Web of Science ®Google Scholar
• Gardiner CM, Meara AO, Reen DJ. Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 1998; 91: 207–13
   PubMed Web of Science ®Google Scholar
• Harris DT, Schumacher MJ, Locascio J, et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992; 89: 10006–10
   PubMed Web of Science ®Google Scholar
• Roth I, Corry DB, Locksley RM, et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184: 539–48
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191–3
   PubMed Web of Science ®Google Scholar
• Szekeres-Bartho J, Faust Z, Varga P, et al. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production. Am J Reprod Immunol 1996; 35: 348–51
   PubMed Web of Science ®Google Scholar
• Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn?. Clin Exp Immunol 2005; 141: 10–8
   PubMed Web of Science ®Google Scholar
• Marodi L. Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 2002; 128: 1–2
   PubMedGoogle Scholar
• Guller S, LaChapelle L. The role of placental Fas ligand in maintaining immune privilege at maternal–fetal interfaces. Semin Reprod Endocrinol 1999; 17: 39–44
   PubMedGoogle Scholar
• Ribeiro-do-Couto LM, Boeije LC, Kroon JS, et al. High IL-13 production by human neonatal T cells: neonate immune system regulator?. Eur J Immunol 2001; 31: 3394–402
   Google Scholar
• White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO− T cells. J Immunol 2002; 168: 2820–7
   PubMed Web of Science ®Google Scholar
• Goriely S, Van Lint C, Dadkhah R, et al. A defect in nucleosome remodeling prevents IL-12(p35) gene transcription in neonatal dendritic cells. J Exp Med 2004; 199: 1011–6
   PubMed Web of Science ®Google Scholar
• Goriely S, Vincart B, Stordeur P, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166: 2141–6
   PubMed Web of Science ®Google Scholar
• Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002; 128: 118–23
   PubMed Web of Science ®Google Scholar
• Klein AK, Patel DD, Gooding ME, et al. T-cell recovery in adults and children following umbilical cord blood transplantation. Biol Blood Marrow Transplant 2001; 7: 454–66
   PubMed Web of Science ®Google Scholar
• Moretta A, Maccario R, Fagioli F, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371–9
   PubMed Web of Science ®Google Scholar
• Brahmi Z, Hommel-Berrey G, Smith F, Thomson B. NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum Immunol 2001; 62: 782–90
   PubMed Web of Science ®Google Scholar
• Niehues T, Rocha V, Filipovich AH, et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children: a Eurocord analysis. Br J Haematol 2001; 114: 42–8
   PubMed Web of Science ®Google Scholar
• Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703–11
   PubMed Web of Science ®Google Scholar
• Parkman RCG, Carter SL, Weinberg K , et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant 2006;12:919–27.
   PubMed Web of Science ®Google Scholar
• Szabolcs P, Niedzwiecki D, Chao N, Kurtzberg J. Multivariate analysis of patient and graft specific factors among 330 recipients of unrelated cord blood transplant (UCBT) to predict risk of death from opportunistic infections in the first 6 months after UCBT. Blood 2006; 108: 2860a
   Google Scholar
• Szabolcs P, Park KD, Marti L, et al. The impact of immune reconstitution in the early post grafting period on the development of opportunistic infections after unrelated cord blood transplantation: a multivariate analysis of host, graft, and day +50 immune profile. Biol Blood Marrow Transplant 2004; 10(Suppl 1)48
   Google Scholar
• Szabolcs P, Park KD, Reese M, et al. Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method. Stem Cells 2003; 21: 296–303
   Google Scholar
• Szabolcs P, Park KD, Marti L, et al. Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2 immunotoxin. Biol Blood Marrow Transplant 2004; 10: 772–83
   PubMed Web of Science ®Google Scholar
• Hamann D, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997; 186: 1407–18
   PubMed Web of Science ®Google Scholar
• Hamann D, Kostense S, Wolthers KC, et al. Evidence that human CD8+CD45RA+CD27− cells are induced by antigen and evolve through extensive rounds of division. Int Immunol 1999; 11: 1027–33
   PubMed Web of Science ®Google Scholar
• Hakim FT, Memon SA, Cepeda R, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 2005; 115: 930–9
   PubMed Web of Science ®Google Scholar
• Szabolcs P, Lee YA, Reese M, et al. Rapid in vivo acquisition of effector Tc1 phenotype prior to myeloid engraftment predicts opportunistic infections in unrelated cord blood transplant recipients. Biol Blood Marrow Transplant 2006; 12(Supple 1)238
   Google Scholar